Author: chris

The american dream , is it still valid?

The history of jazz music.

1. Explain how and why modern biotechnology has evolved. Make sure to provide in your answer

   how biotechnology and pharmaceutical companies differ. Include in your discussion the big

   pharma approach as well as the novel approach employed by biotechnology. Incorporate the 3

   characteristics that describe biotechnology.

2. Discuss the history of how biotechnology partnering strategies evolved. Use Genentech as an

   example.

3. Explain the objectives of the preclinical phase of development. How does a company decide to

   go forward with initiating a clinical trial? What types of communication is necessary with the

   FDA to initiate a Phase I trial?

4. What are the clinical phases of drug development? Provide a summary of the objectives of

   each. Give an example of success at each stage.

5. Provide a detailed discussion of the approval process. Make sure to define and differentiate

   between accelerated approval, fast track status and priority review. What role does the

   advisory committee play?

6. What is the Hatch-Waxman Act and why was it enacted? What does it allow for? How is it

   applicable to generics?

7. What are Orphan Drugs? Why have orphan drugs historically not been the focus of drug

   development in early-stage biotechnology companies?

8. How does a start-up biotechnology company begin? Explain how management teams are

   usually structured

1. Explain how and why modern biotechnology has evolved. Make sure to provide in your answer

   how biotechnology and pharmaceutical companies differ. Include in your discussion the big

   pharma approach as well as the novel approach employed by biotechnology. Incorporate the 3

   characteristics that describe biotechnology.

2. Discuss the history of how biotechnology partnering strategies evolved. Use Genentech as an

   example.

3. Explain the objectives of the preclinical phase of development. How does a company decide to

   go forward with initiating a clinical trial? What types of communication is necessary with the

   FDA to initiate a Phase I trial?

4. What are the clinical phases of drug development? Provide a summary of the objectives of

   each. Give an example of success at each stage.

5. Provide a detailed discussion of the approval process. Make sure to define and differentiate

   between accelerated approval, fast track status and priority review. What role does the

   advisory committee play?

6. What is the Hatch-Waxman Act and why was it enacted? What does it allow for? How is it

   applicable to generics?

7. What are Orphan Drugs? Why have orphan drugs historically not been the focus of drug

   development in early-stage biotechnology companies?

8. How does a start-up biotechnology company begin? Explain how management teams are

   usually structured

1. Explain how and why modern biotechnology has evolved. Make sure to provide in your answer

   how biotechnology and pharmaceutical companies differ. Include in your discussion the big

   pharma approach as well as the novel approach employed by biotechnology. Incorporate the 3

   characteristics that describe biotechnology.

2. Discuss the history of how biotechnology partnering strategies evolved. Use Genentech as an

   example.

3. Explain the objectives of the preclinical phase of development. How does a company decide to

   go forward with initiating a clinical trial? What types of communication is necessary with the

   FDA to initiate a Phase I trial?

4. What are the clinical phases of drug development? Provide a summary of the objectives of

   each. Give an example of success at each stage.

5. Provide a detailed discussion of the approval process. Make sure to define and differentiate

   between accelerated approval, fast track status and priority review. What role does the

   advisory committee play?

6. What is the Hatch-Waxman Act and why was it enacted? What does it allow for? How is it

   applicable to generics?

7. What are Orphan Drugs? Why have orphan drugs historically not been the focus of drug

   development in early-stage biotechnology companies?

8. How does a start-up biotechnology company begin? Explain how management teams are

   usually structured

1. Explain how and why modern biotechnology has evolved. Make sure to provide in your answer

   how biotechnology and pharmaceutical companies differ. Include in your discussion the big

   pharma approach as well as the novel approach employed by biotechnology. Incorporate the 3

   characteristics that describe biotechnology.

2. Discuss the history of how biotechnology partnering strategies evolved. Use Genentech as an

   example.

3. Explain the objectives of the preclinical phase of development. How does a company decide to

   go forward with initiating a clinical trial? What types of communication is necessary with the

   FDA to initiate a Phase I trial?

4. What are the clinical phases of drug development? Provide a summary of the objectives of

   each. Give an example of success at each stage.

5. Provide a detailed discussion of the approval process. Make sure to define and differentiate

   between accelerated approval, fast track status and priority review. What role does the

   advisory committee play?

6. What is the Hatch-Waxman Act and why was it enacted? What does it allow for? How is it

   applicable to generics?

7. What are Orphan Drugs? Why have orphan drugs historically not been the focus of drug

   development in early-stage biotechnology companies?

8. How does a start-up biotechnology company begin? Explain how management teams are

   usually structured

Directions: Choose one of the types of interactions among community members described within your text. Define whichever interaction you select, give an example that is unique to classmates who post before you, and describe what (if anything) each organisms contributes, gains, or loses in the interaction.

Directions: Choose one of the types of interactions among community members described within your text. Define whichever interaction you select, give an example that is unique to classmates who post before you, and describe what (if anything) each organisms contributes, gains, or loses in the interaction.